Bioactivity | 17R-Resolvin D1 is an aspirin-triggered epimer of Resolvin D1, which exhibits anti-inflammatory activity in mice and human PMNs cells[1]. 17R-Resolvin D1 specificially inhibits TRPV3 with an IC50 of 398 nM and exhibits peripheral anti-nociceptive efficacy[2]. |
Invitro | 17R-Resolvin D1 (0-1000 nM) 剂量依赖性地减少 fMLP 诱导的人多形核白细胞 (PMN) 的跨内皮迁移,发挥抗急性炎症的作用[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> 17(R)-Resolvin D1 相关抗体: Cell Migration Assay [1] Cell Line: |
In Vivo | 17R-Resolvin D1 (0.05-50 μg/kg,静脉注射) 减少 FVB 小鼠体内的 PMN 细胞浸润,在 100 ng/kg 剂量时达到最大抑制浓度,一直比例为 35%[1]。17R-Resolvin D1 (30 µM in 20 µL,皮内注射) TRPV3 特异性地减轻 ICR 小鼠体内由 CFA 诱导的急性疼痛[2]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
CAS | 528583-91-7 |
Formula | C22H32O5 |
Molar Mass | 376.49 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Sun YP, et al., Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem. 2007 Mar 30;282(13):9323-9334. [2]. Bang S, et al., 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. Br J Pharmacol. 2012 Feb;165(3):683-92. |